Science Translational Medicine · 2017 · 111 citations · 37 references
MedicineCancer BiologyOncologyMolecular OncologySignal TransductionTumor MicroenvironmentApoptosis ResistanceBreast Cancer PharmacotherapyCancer Cell SignalingHer2-positive Breast CancerSignal Transduction In CancerTumor Microenvironment ModulationBreast Cancer Resistance MechanismsHer2 DependenceHer2-positive Breast Cancer TherapyPi3 Kinase-akt SignalingPi3k InhibitorsPi3k SignalingPi3k-akt Signaling PathwayPik3ca Mutations
The brain microenvironment triggers HER3-dependent de novo resistance to therapies targeting PI3K or HER2 in HER2-positive and/or PIK3CA -mutant breast cancer cells.
37
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
José Baselga, Javier Cortés, Sung‐Bae Kim et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text
Medicine, Oncology, Pharmacology +12
Multiple essential functions of neuregulin in development
Dirk Meyer, Carmen Birchmeier · Nature · 1995 · 1.3K citations
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast, Louisa von Baumgarten, Martin Fuhrmann et al. · Nature Medicine · 2009 · 1.1K citations
Medicine, Cancer Biology, Oncology +15